IDEAS home Printed from https://ideas.repec.org/h/spr/mgmchp/978-3-030-02363-8_32.html
   My bibliography  Save this book chapter

Sanofi–Aventis Merger

In: Wealth Creation in the World’s Largest Mergers and Acquisitions

Author

Listed:
  • B. Rajesh Kumar

    (Institute of Management Technology)

Abstract

In the year 2004 after a bitter takeover battle, France’s largest drug maker, Aventis, agreed to be absorbed by a smaller rival company Sanofi-Synthelabo SA in a cash and stock deal valued for Euro 55.2 billion ($65 billion). At the time of the deal, the consolidation created the world’s third largest pharmaceutical company with a market capitalization of approximately 90 billion euros behind US-based Pfizer and Britain’s GlaxoSmithKline. The French government put pressure on Sanofi-Synthelabo to raise its bid for Aventis and for Aventis to accept the offer. Under the terms of the revised bid, Sanofi offered five of its shares for each Aventis shares held plus €120 in cash. During the −78 to +173 (254-day merger period) covering January 1, 2004–January 2005, the Aventis stock gained 9.20% on cumulative basis.

Suggested Citation

  • B. Rajesh Kumar, 2019. "Sanofi–Aventis Merger," Management for Professionals, in: Wealth Creation in the World’s Largest Mergers and Acquisitions, chapter 32, pages 277-280, Springer.
    • Handle: RePEc:spr:mgmchp:978-3-030-02363-8_32
    DOI: 10.1007/978-3-030-02363-8_32
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:mgmchp:978-3-030-02363-8_32. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.